Molecular Characterisation of Fungi from Mycotic Keratitis and Invasive Infections and Comparison with Conventional Methods
Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 3
Abstract
ABSTRACT Introduction: Fungi can cause systemic or localised infections in human beings, among which mycotic keratitis and Invasive Fungal Infections (IFIs) are very important, which can lead to severe complications and fatal consequences. In some instances, fungal culture isolates may not be identified accurately on the basis of morphology and microscopy. In those cases, molecular characterisation of isolates becomes more helpful in identification, which is essential for providing appropriate antifungal therapy and avoiding bad prognosis. Aim: To identify the fungi collected from patients of mycotic keratitis and IFIs (diagnosed by conventional methods) using molecular methods and to compare the results with the results of conventional methods of identification. Materials and Methods: In the present prospective study, fungal culture isolates were taken from 24 keratomycosis and seven IFIs patients (diagnosed by conventional methods) reporting to the OPD and wards of AIIMS Hospital, Delhi, India (March 2016 to March 2017). Isolates were further subcultured for DNA isolation and amplification for the variable ITS1 and ITS2 regions, and processed for nucleotide sequencing. The obtained sequences for ITS1 and ITS2 regions were searched for homology with NCBI-BLAST program. Results of molecular diagnosis at species level were compared with the conventional methods. Results: Conventional methods could identify Fusarium spp., Alternaria spp., Bipolaris spp., Cladosporium spp., Penicillium spp., Rhizopus spp., up to genus level only, which could be further identified up to species level by molecular methods. Phenotypically identified isolates of Acremonium spp. was identified as Simplicillium spp., Alternaria spp. as Chaetomium globosum, Mucor spp. as Rhizopus oryzae by molecular methods. Conclusion: As prognosis and therapy varies among different genera of fungi and in some cases from species to species, correct species level identification is important; hence, molecular methods may be complemented to traditional methods. Identification of rare fungal isolates is also important in clinical mycology, so that they will not be discarded as contaminants, which is possible using molecular techniques.
Authors and Affiliations
Deepankar Srigyan, Himanshu Sekhar Behera, Gita Satpathy, Nishat Hussain Ahmed, Namrata Sharma, Radhika Tandon, Immaculata Xess, Jeewan Singh Titiyal
Keywords
Related Articles
- EP ID EP502134
- DOI 10.7860/JCDR/2018/34188.11301
- Views 94
- Downloads 0
Catalysing Public Healthcare Efficacy: Striking the Right Cords of Leadership
Abstract Introduction: Leaders’ behaviour significantly influences the job satisfaction of the employees. Hospital experience and patient outcomes relate to job satisfaction of employee’s working therein. Aim: Current...
Thyroid Disorders in Pregnancy: An Exploratory Study
ABSTRACT Introduction: Thyroid disorders, mostly hypothyroidism, being one of the common diseases during pregnancy, if untreated, affect the neuro-psycho development of neonates. Many factors influence thyroid function t...
Therapeutic Plasma Exchange - An Emerging Treatment Modality in Patients with Neurologic and Non-Neurologic Diseases
Introduction: Therapeutic Plasma Exchange (TPE) is a procedure in which the patient’s blood is passed through an apheresis machine, where the filtered plasma is removed and discarded with reinfusion of red blood cells al...
Is Interleukin-18 an Early Diagnostic Biomarker in Contrast Induced Nephropathy?
Abstract Introduction: The rise in number of cases of hospital-acquired acute kidney injury in patients undergoing diagnostic and therapeutic procedures by the use of contrast medium is a growing concern among nephrologi...
Efficacy of Combination Therapy of Rosuvastatin and Ezetimibe vs Rosuvastatin Monotherapy on Lipid Profile of Patients with Coronary Artery Disease
Introduction: Dyslipidaemia is one of the most important modifiable risk factor for the development of Coronary Artery Disease (CAD). Although, statins are established as first line lipid-lowering therapy, they may not b...